Efficacy of DLBS1033 in Patients With Acute Ischemic Stroke
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This is a 3-arm, prospective, randomized, double-blind, and controlled clinical study, with 3
months of treatment to evaluate efficacy of DLBS1033 in bleeding profile and clinical outcome
in patients with acute ischemic stroke compared with aspirin and clopidogrel, as active
controls.